Can We Pharmacologically Target Dishevelled: The Key Signal Transducer in the Wnt Pathways?

Investor logo

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Science. Official publication website can be found on muni.cz.

Authors

MICKA Miroslav BRYJA Vítězslav

Year of publication 2021
Type Chapter of a book
MU Faculty or unit

Faculty of Science

Citation
Description Dishevelled (DVL) is the central signal transducer in both Wnt/ß-catenin-dependent and independent signalling pathways. DVL is required to connect receptor complexes and downstream effectors. Since proximal Wnt pathway components and DVL itself are upregulated in many types of cancer, DVL represents an attractive therapeutic target in the Wnt-addicted cancers and other disorders caused by aberrant Wnt signalling. Here, we discuss progress in several approaches for the modulation of DVL function and hence inhibition of the Wnt signalling. Namely, we sum up the potential of modulation of enzymes that control post-translational modification of DVL - such as inhibition of DVL kinases or promotion of DVL ubiquitination and degradation. In addition, we discuss research directions that can take advantage of direct interaction with the protein domains essential for DVL function: the inhibition of DIX- and DEP-domain mediated polymerization and interaction of DVL PDZ domain with its ligands.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.